Published June 2, 2026 Updated August 27, 2026 8 min read # The FINGER trial: can lifestyle change the trajectory? ## The short version A two-year structured program of diet, exercise, cognitive training, and vascular care modestly improved cognition in at-risk older adults, including APOE4 carriers. That is not proof of lifelong dementia prevention. Copy the ingredients; do not wait for a clinic program. By the OutliveAPOE4 editorial team. [How we research & source](/methodology). Plenty of studies show that healthy people get less dementia. The hard question is whether changing your behavior actually moves your own trajectory. The FINGER trial (the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability, a two-year multidomain lifestyle program) is the best attempt yet to answer that, and the answer is cautiously yes: over two years, a combined lifestyle program improved cognitive scores by about 25% on the overall test battery versus a control group. The part that matters most for you is the follow-up: APOE4 carriers benefited at least as much as everyone else. ## What FINGER did FINGER (the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability) was a randomized controlled trial, the gold-standard design, in adults aged 60 to 77 who were already at risk of decline. For two years, one group got a multidomain intervention that combined four things at once: - Nutritional guidance (a healthy, Mediterranean-style pattern) - Physical exercise (aerobic and strength) - Cognitive training - Monitoring and management of vascular and metabolic risk factors The control group got general health advice. The design is the point: it tested the whole package, not a single magic ingredient. ## A 25 percent edge on the test battery The intervention group’s cognitive scores improved over the two years while the control group stayed roughly flat, a gap of about 25% on the overall neuropsychological test battery (and larger on executive function and processing speed). It was modest but statistically significant, meaning it is unlikely to be chance, and the direction is what counts: the trained group got better, the control group did not. The headline is not any single component. It is that a combined, real-world lifestyle program can benefit cognition in at-risk older adults. FINGER moved dementia prevention from “plausible” toward “actionable.” It helps to picture how intensive this was, because the dose is not a pamphlet. Participants did supervised gym sessions multiple times a week, structured cognitive-training sessions, regular dietitian visits, and nurse-led monitoring of blood pressure and metabolic markers, for two full years. Casual dabbling is not the same intervention. ## The crucial APOE4 detail For this audience, the most important result is the genotype follow-up. A [prespecified analysis of APOE genotype](https://pubmed.ncbi.nlm.nih.gov/29356827/) (Solomon and colleagues, *JAMA Neurology* 2018), meaning it was planned in advance rather than fished out afterward, found that APOE4 carriers benefited from the intervention at least as much as non-carriers, and on some measures numerically more, with no sign that carrying ε4 blunted the response. The honest caveat is that the carrier subgroup was not large enough to prove carriers benefit more, only that they clearly benefit. Either way it directly counters the fatalistic “why bother, it’s genetic” story: in the best lifestyle-prevention trial we have, the people with the risk gene still gained. Newer evidence pushes this further. A 2025 [meta-analysis pooling three multidomain trials](https://pmc.ncbi.nlm.nih.gov/articles/PMC12726239/) (FINGER plus the French MAPT and the Japanese J-MINT) tested the APOE-by-intervention question head-on, and found a statistically significant interaction (p = 0.035) pointing the other way from the fatalist’s intuition: ε4 carriers appeared to benefit more from the lifestyle program than non-carriers, consistently across European and Asian cohorts. This is pooled observational-within-trial evidence, not a single definitive RCT in carriers, so treat it as suggestive rather than settled. But the direction matters: the group with the most genetic risk may have the most to gain from doing the work. ## A global movement FINGER inspired World-Wide FINGERS, a network of similar trials adapting the model across different countries and populations. The biggest is the [U.S. POINTER study](/topics/us-pointer-trial-and-lifestyle) (about 2,000 older adults at risk), which reported in 2025 that a structured multidomain lifestyle program improved global cognition over two years, with the structured and supervised version outperforming a self-guided one. POINTER matters because it replicates FINGER in a large, diverse US population, which strengthens the core message that the effect is not a Finnish fluke. Not every trial landed identically, though: MAPT, a French trial, had more mixed results, a fair reminder that the size and intensity of the program matter. ## Carriers were not left out of the benefit - It supports the central premise of this site: the modifiable levers, pursued together, may meaningfully influence the trajectory, in line with the WHO’s emphasis on risk reduction. - The intervention is essentially the package we cover throughout: diet, exercise, cognitive and social engagement, and vascular health, rather than a pill or a single hack. - The genotype analysis says carriers are not excluded from the benefit. If anything, it is an argument to start. ## What two years of FINGER cannot promise - FINGER measured cognitive performance over two years, not a lifetime of dementia outcomes. Longer trials are ongoing. - Effects were at the group level, and individuals vary. - The intervention was a supported, structured program. Doing it alone takes more intention. ## Copy the ingredients, not the waiting You cannot replicate a research trial at home, but you can run its components. Build the same four levers into your week: a [Mediterranean-style diet](/topics/mediterranean-diet-metabolome-apoe4-dementia), regular [exercise](/topics/exercise-and-apoe4) with both aerobic and strength work, cognitive and social engagement, and tight [blood-pressure](/topics/blood-pressure-and-brain-health) and metabolic control. Treat it as a structured habit, not occasional dabbling, ideally with a clinician’s input, since the dose mattered in the trial. ## Common questions **What if I can only do two of the four pieces?** The trial bundled them, so we cannot rank diet versus exercise from this study alone. Start with the pieces you can keep every week rather than waiting until all four look perfect. > The takeaway is empowering and well-grounded: a combined lifestyle program can support cognition in at-risk adults, carriers included. For carriers, that is the strongest kind of motivation, evidence that the levers you control are worth pulling, together and early. ## Sources & further reading 1. [Ngandu et al. (2015), The Lancet: FINGER, a 2-year multidomain intervention](https://pubmed.ncbi.nlm.nih.gov/25771249/) 2. [World Health Organization: Dementia (risk reduction)](https://www.who.int/news-room/fact-sheets/detail/dementia) 3. [Solomon et al. (2018), JAMA Neurology: APOE genotype and the FINGER intervention effect](https://pubmed.ncbi.nlm.nih.gov/29356827/) 4. [Meta-analysis (2025), PMC: Effect of ApoE genotype on multidomain lifestyle interventions across three RCTs (FINGER, MAPT, J-MINT)](https://pmc.ncbi.nlm.nih.gov/articles/PMC12726239/) ## Related deep dives - [US POINTER: The American FINGER Trial Finally Reports, and What It Means for Carriers A 2,111-person US randomized trial just showed a structured lifestyle program protects thinking in at-risk older adults, and it enrolled the exact profile many carriers have.](/topics/us-pointer-trial-and-lifestyle) - [How much exercise should APOE4 carriers get? A practical weekly exercise target for APOE4 carriers, why cardio and strength protect different systems, and how to start without treating exercise as a guarantee.](/topics/exercise-and-apoe4) - [Which diet is best supported for APOE4 brain health? Mediterranean and MIND diets have the strongest overall brain-health evidence. Here is what they share, where APOE4-specific evidence is limited, and how to apply them.](/topics/mediterranean-and-mind-diets) - [Blood pressure and brain health High blood pressure is one of the best-established modifiable risk factors for dementia. Why it matters so much for APOE4 carriers, the numbers, and how to keep it in range.](/topics/blood-pressure-and-brain-health)